Clinical Trial Update: Study of Efficacy and Safety of GR1501 in Patients with Radiographic Axial Spondyloarthritis [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating GR1501 for efficacy and safety in radiographic axial spondyloarthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Axial Spondyloarthritis

Drugs mentioned

• GR1501

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Axial Spondyloarthritis | Phase 3 | Status: COMPLETED